Gene S is a Western Australian based start-up biotechnology company providing accessible, affordable, rapid and reliable genetic solutions to facilitate personalised prescription therapies to improve the health and wellbeing of the population. The company has a novel, innovative and disruptive technology that provides personalised prescription medication using pharmacogenomics and a precise detection method. This personalised precision prescription medical device will assist doctors in prescribing the right medication at the right dose the first time. The technology will allow doctors to assess a patient’s genetic profile (their individual prescriptome) to specific medication pathways. This will ensure that patients receive the optimum treatment roadmap, reduce the risk of medication side effects and save governments billions of dollars every year in healthcare costs.